Search Results - "Kichula, Elizabeth"

Refine Results
  1. 1

    Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy by Kichula, Elizabeth A., Proud, Crystal M., Farrar, Michelle A., Kwon, Jennifer M., Saito, Kayoko, Desguerre, Isabelle, McMillan, Hugh J.

    Published in Muscle & nerve (01-10-2021)
    “…Spinal muscular atrophy (SMA) is an autosomal recessive, neurodegenerative disease caused by biallelic mutations in the survival motor neuron 1 (SMN1) gene…”
    Get full text
    Journal Article
  2. 2

    Clinical Experience With Gene Therapy in Older Patients With Spinal Muscular Atrophy by Matesanz, Susan E., Battista, Vanessa, Flickinger, Jean, Jones, Jennifer N., Kichula, Elizabeth A.

    Published in Pediatric neurology (01-05-2021)
    “…Onasemnogene abeparvovec was recently approved for the treatment of spinal muscular atrophy (SMA) in children younger than two years; however, clinical trials…”
    Get full text
    Journal Article
  3. 3

    Clinical Course in a Patient With Spinal Muscular Atrophy Type 0 Treated With Nusinersen and Onasemnogene Abeparvovec by Matesanz, Susan E., Curry, Candace, Gross, Brianna, Rubin, Adam I., Linn, Rebecca, Yum, Sabrina W., Kichula, Elizabeth A.

    Published in Journal of child neurology (01-10-2020)
    “…Spinal muscular atrophy type 0 is the most severe phenotype of the disease, with patients presenting with contractures, weakness, and respiratory failure at…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Developmental and comparative aspects of posterior medial thalamocortical innervation of the barrel cortex in mice and rats by Kichula, Elizabeth A., Huntley, George W.

    Published in Journal of comparative neurology (1911) (20-07-2008)
    “…The thalamocortical projection to the rodent barrel cortex consists of inputs from the ventral posterior medial (VPM) and posterior medial (POm) nuclei that…”
    Get full text
    Journal Article
  7. 7

    A multidisciplinary approach to dosing nusinersen for spinal muscular atrophy by Zingariello, Carla D, Brandsema, John, Drum, Elizabeth, Henderson, Alicia A, Dubow, Scott, Glanzman, Allan M, Mayer, Oscar, Yum, Sabrina W, Kichula, Elizabeth A

    Published in Neurology. Clinical practice (01-10-2019)
    “…In December 2016, nusinersen gained FDA approval as the first pharmacologic treatment for spinal muscular atrophy (SMA), a disorder of motor neurons and the…”
    Get full text
    Journal Article
  8. 8

    Familial Dysautonomia Is Caused by Mutations of the IKAP Gene by Anderson, Sylvia L., Coli, Rocco, Daly, Ira W., Kichula, Elizabeth A., Rork, Matthew J., Volpi, Sabrina A., Ekstein, Josef, Rubin, Berish Y.

    Published in American journal of human genetics (01-03-2001)
    “…The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Frataxin Restoration in the Nervous System: Possibilities for Gene Therapy by Lynch, David R., Kichula, Elizabeth, Lin, Hong

    Published in Molecular therapy (01-08-2018)
    “…[...]this approach provides a rationale at the level of frataxin expression for one component of the selective neuronal vulnerability in FRDA. [...]this model…”
    Get full text
    Journal Article
  12. 12

    Challenges ahead for trials in Friedreich’s ataxia by Lynch, David R, Kichula, Elizabeth

    Published in Lancet neurology (01-12-2016)
    “…The disorder results from expansion of GAA repeats in the FXN gene, which leads to deficiency of frataxin, a small protein that is thought to be required for…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Inherited Neuromuscular Disorders: Presentation, Diagnosis, and Advances in Treatment by Kichula, Elizabeth A.

    “…Purpose of Review This article reviews presentation of inherited neuromuscular disorders, including how to differentiate them from other causes of hypotonia…”
    Get full text
    Journal Article
  18. 18

    Friedreich Ataxia: Multidisciplinary Clinical Care by Lynch, David R, Schadt, Kim, Kichula, Elizabeth, McCormack, Shana, Lin, Kimberly Y

    Published in Journal of multidisciplinary healthcare (01-01-2021)
    “…Friedreich ataxia (FRDA) is a multisystem disorder affecting 1 in 50,000-100,000 person in the United States. Traditionally viewed as a neurodegenerative…”
    Get full text
    Journal Article
  19. 19
  20. 20